IT IS USED FOR THE CONTROL OF NAUSEA AND VOMITING ASSOCIATED WITH CANCER CHEMOTHERAPY IN PATIENTS WHO HAVE FAILED TO RESPOND ADEQUATELY TO CONVENTIONAL ANTIEMETICS.
INITIALLY 1 MG TWICE DAILY, INCREASED IF NECESSARY TO 2 MG TWICE DAILY, THROUGHOUT EACH CYCLE OF CYTOTOXIC THERAPY AND, IF NECESSARY, FOR 48 HOURS AFTER THE LAST DOSE OF EACH CYCLE; MAX. 6 MG DAILY GIVEN IN 3 DIVIDED DOSES. THE FIRST DOSE SHOULD BE TAKEN THE NIGHT BEFORE INITIATION OF CYTOTOXIC TREATMENT AND THE SECOND DOSE 1 - 3 HOURS BEFORE THE FIRST DOSE OF CYTOTOXIC DRUG; ADOLESCENT AND CHILD UNDER 18 YEARS CONSULT LOCAL TREATMENT PROTOCOL [UNLICENSED USE]